(Q40247950)

18 September 2017

1 reference

title

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease (English)

1 reference

18 September 2017

I J Fidler

1

1 reference

PubMed ID

6755782

18 September 2017

G Poste

series ordinal

2

1 reference

18 September 2017

1 January 1982

1 reference

Seminars in Immunopathology

18 September 2017

1 reference

18 September 2017

5

1 reference

18 September 2017

161-174

1 reference

18 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00199794

18 September 2017

0 references

cites work

Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages

1 reference

12 December 2020

Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages

1 reference

12 December 2020

Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages

1 reference

12 December 2020

The implications of tumor heterogeneity for studies on the biology of cancer metastasis

1 reference

12 December 2020

In situ activation of murine macrophages by liposomes containing lymphokines

1 reference

12 December 2020

Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities

1 reference

12 December 2020

The pathogenesis of cancer metastasis

1 reference

12 December 2020

Macrophage content of metastatic and nonmetastatic rodent neoplasms

1 reference

12 December 2020

Role of natural killer cells in the destruction of circulating tumor emboli

1 reference

12 December 2020

Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice

1 reference

12 December 2020

In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes

1 reference

12 December 2020

Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.

1 reference

12 December 2020

Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide

1 reference

12 December 2020

Properties of metastatic and nonmetastatic cloned subpopulations of an ultraviolet-light-induced murine fibrosarcoma of recent origin

1 reference

12 December 2020

The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process

1 reference

12 December 2020

Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis

1 reference

12 December 2020

Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity

1 reference

12 December 2020

Synthetic immunostimulants derived from the bacterial cell wall

1 reference

12 December 2020

Implications of immunological heterogeneity of tumours

1 reference

12 December 2020

Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages

1 reference

12 December 2020

Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines

1 reference

12 December 2020

Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.

1 reference

12 December 2020

The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes

1 reference

12 December 2020

Cell surface receptors for lymphokines. I. The possible role of glycolipids as receptors for macrophage migration inhibitory factor (MIF) and macrophage activation factor (MAF).

1 reference

12 December 2020

Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases

1 reference

12 December 2020

Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity

1 reference

12 December 2020

The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells

1 reference

12 December 2020

Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes

1 reference

12 December 2020

Brief Communication: Tumor Suppression by a Lymphokine Released Into the Circulation of Mice With Delayed Hypersensitivity 2

1 reference

12 December 2020

Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas

1 reference

12 December 2020

In vitro tumoricidal activity of macrophages against virus-transformed lines with temperature-dependent transformed phenotypic characteristics

1 reference

12 December 2020

Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A

1 reference

12 December 2020

Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line

1 reference

12 December 2020

Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines

1 reference

12 December 2020

Reduction of tumour cell entry into vessels by BCG-activated macrophages

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199794

1 reference

18 September 2017

1 reference

PubMed ID

6755782